Who can prescribe Vyvanse? In Australia, Vyvanse (lisdexamfetamine) can be prescribed by psychiatrists, paediatricians, neurologists, and — as of 2025–2026 — an expanding category of specially trained GPsdepending on the state and the clinical context. The prescribing landscape changed significantly with two landmark reforms: NSW’s September 2025 GP continuation prescriber rollout and Queensland’s December 2025 reform making it the first Australian state to allow specialist GPs to both diagnose ADHD and initiate stimulant medication for adults. However, the rules differ by state, by whether you are a new or existing patient, and by whether the GP has completed specific accredited training — meaning the answer “a GP can prescribe Vyvanse” is true in some contexts and legally incorrect in others.
The Two Core Prescriber Categories
Before examining state-by-state rules, it is essential to understand the two fundamental categories of Vyvanse prescribing authority in Australia:
Category 1: Specialist Initiating Prescribers
These clinicians can diagnose ADHD and start Vyvanse for new patients:
- Psychiatrists — full authority in all states and territories; no S8 permit required in most jurisdictions for standard ADHD prescribing within approved dose limits
- Paediatricians — full authority for children and adolescents in all states
- Neurologists — authorised in NSW, WA, and under the national class authority from November 2023
- Endorsed/specialist GPs (Queensland from December 2025, NSW from March 2026 onwards) — specially trained and credentialled GPs with additional authority to diagnose and initiate
Category 2: Continuation Prescribers
These clinicians can only prescribe Vyvanse for existing patients who already have a specialist diagnosis and are stable on medication:
- GP continuation prescribers — GPs who have completed specific accredited training and applied for and received continuation prescriber status under state frameworks
- GPs under shared care/co-management arrangements — GPs with a formal documented arrangement with the specialist who initiated treatment; permitted in all states
- Other registered medical practitioners — can apply for individual patient approval in most states where a co-management arrangement with a specialist exists
Who Cannot Prescribe Vyvanse in Australia
As important as who can prescribe is a clear statement of who cannot:
- Nurse practitioners — explicitly excluded from prescribing Schedule 8 psychostimulants in NSW and most other states
- GPs without continuation prescriber registration or co-management arrangements — cannot prescribe Vyvanse under PBS authority regardless of their knowledge of the patient
- GP registrars and non-vocational registration GPs — excluded even in Queensland’s expanded framework, which requires FRACGP or FACRRM fellowship
- Psychologists — can conduct ADHD assessments and contribute to diagnosis, but have no prescribing authority for any medication
- Clinical pharmacists — no Schedule 8 prescribing authority for stimulants in any Australian jurisdiction
- Other specialists (respiratory physicians, palliative care, rehabilitation physicians) — can apply for individual patient approval in NSW but are not authorised under the class authority for standard ADHD prescribing
The 2025–2026 GP Prescribing Reforms: The Most Important Recent Change
Australia’s ADHD prescribing rules are undergoing the most significant reform since Vyvanse was listed on the PBS in 2019. Understanding the current state of these reforms is essential for patients and prescribers alike.
The RACGP National Position
The Royal Australian College of General Practitioners (RACGP) is actively advocating for nationally consistent legislation to allow specialist GPs to initiate, modify, and continue psychostimulants for adults and children with ADHD across all states. The current situation — described by the RACGP as a “patchwork” — means that what a GP can legally do for a patient with ADHD depends entirely on which Australian state they are working in.
The Two-Tier NSW Model
NSW has implemented the most detailed and structured GP reform framework:
Tier 1 — Continuation Prescribers (operative from 1 September 2025):
- Trained GPs who have applied and been granted continuation prescriber status can issue ongoing psychostimulant prescriptions for patients aged 6+ with a prior specialist diagnosis who are stable on medication
- As of 27 January 2026, 749 GP continuation prescribers are registered in NSW, with 41% located outside metropolitan Sydney
- Continuation prescribers can also make minor dose adjustments within the approved dose range
Tier 2 — Endorsed Prescribers (commenced March 2026):
- A smaller group of GPs who have completed additional accredited assessment training and mentoring — the RACGP describes approximately 100 GPs in this tier
- Endorsed prescribers can conduct full ADHD assessments, make formal diagnoses, and initiate stimulant medications including Vyvanse
- Endorsed prescribers are Fellows of the RACGP or ACRRM (FRACGP or FACRRM) with the specific additional training completed
State-by-State Prescribing Authority: 2026
The prescribing authority for Vyvanse varies significantly by jurisdiction. This is the most critical practical information for Australian patients and prescribers:
New South Wales
| Prescriber Type | Can Initiate (New Patients)? | Can Continue (Existing Patients)? |
|---|---|---|
| Psychiatrist | ✅ Yes — class authority | ✅ Yes |
| Paediatrician | ✅ Yes — class authority (children) | ✅ Yes |
| Neurologist | ✅ Yes — class authority | ✅ Yes |
| Endorsed GP (Tier 2, from March 2026) | ✅ Yes — with accreditation | ✅ Yes |
| Continuation GP (Tier 1, from Sep 2025) | ❌ No | ✅ Yes — stable patients only |
| Standard GP (no special status) | ❌ No | ✅ Only via co-management/individual approval |
| Nurse Practitioner | ❌ No | ❌ No |
Key NSW requirement: All S8 psychostimulant prescriptions in NSW must include a valid NSW Health approval number — pharmacists cannot dispense without this. This is enforced via the SafeScript NSW system.
Queensland
Queensland is the most GP-accessible state for ADHD prescribing in Australia as of 2026:
| Prescriber Type | Can Initiate (New Patients)? | Can Continue (Existing Patients)? |
|---|---|---|
| Psychiatrist | ✅ Yes | ✅ Yes |
| Paediatrician | ✅ Yes (children, since 2017) | ✅ Yes |
| Specialist GP (FRACGP/FACRRM) — adults, from Dec 2025 | ✅ Yes — adults 18+ | ✅ Yes |
| Specialist GP (FRACGP/FACRRM) — children, since 2017 | ✅ Yes | ✅ Yes |
| Non-fellowshipped GP | ❌ No | ✅ Via shared care arrangement |
| GP Registrar | ❌ No | ❌ No |
Queensland’s landmark December 2025 reform: From 1 December 2025, Queensland became the first Australian state to allow specialist GPs (FRACGP/FACRRM fellows) to diagnose ADHD and initiate stimulant medication for adults. This is the most significant expansion of ADHD prescribing access in Australian history and establishes Queensland as the national benchmark. Queensland GPs had already had this authority for children since 2017.
Important nuance: This authority is limited to qualified GP fellows (FRACGP/FACRRM) — GP registrars, non-vocational registration GPs, and non-fellowshipped practitioners are explicitly excluded.
Victoria
Victoria’s reform is in earlier stages than NSW and Queensland:
| Prescriber Type | Can Initiate (New Patients)? | Can Continue (Existing Patients)? |
|---|---|---|
| Psychiatrist | ✅ Yes — no permit required | ✅ Yes |
| Paediatrician | ✅ Yes (patients under 18, no permit required) | ✅ Yes |
| GP with S8 permit (co-management) | ❌ No | ✅ Yes — with permit and specialist evidence |
| Trained GP (upcoming 2026 reform) | 🔜 Planned for ~150 GPs | ✅ Yes |
Victoria-specific requirement: Unlike some other states, Victoria requires all GPs — including those in co-management arrangements — to hold a specific Schedule 8 treatment permitbefore prescribing lisdexamfetamine. Having a PBS authority prescription does not satisfy this requirement — it is an offence to prescribe without the permit, even once.
Victoria’s upcoming reform: The RACGP confirms that approximately 150 GPs will be able to undertake training to expand their scope of practice to diagnose, treat, and prescribe ADHD medication for adults and children aged 6+ in Victoria. As of mid-2026, the timeline for implementation has not been confirmed publicly.
The SafeScript requirement in Victoria: All prescribers in Victoria must check the SafeScript database before prescribing S8 medications — this is a mandatory real-time prescription monitoring check. Failure to comply has been reported to the Medical Board.
Western Australia
| Prescriber Type | Can Initiate (New Patients)? | Can Continue (Existing Patients)? |
|---|---|---|
| Psychiatrist | ✅ Yes — with Dept. of Health authority | ✅ Yes |
| Paediatrician | ✅ Yes — with Dept. of Health authority | ✅ Yes |
| Neurologist | ✅ Yes — with Dept. of Health authority | ✅ Yes |
| Rehabilitation/Respiratory/Sleep Physicians | ✅ Yes — with Dept. of Health authority | ✅ Yes |
| GP (Shared Care Model) | ❌ No — cannot initiate | ✅ Yes — with specialist-agreed shared care plan |
| Nurse Practitioner (Shared Care) | ❌ No | ✅ Limited — may prescribe continuing medication under shared care model |
Western Australia’s distinctive feature: WA allows a broader range of specialists than other states to initiate stimulant medication — including rehabilitation doctors, respiratory doctors, and sleep doctors — reflecting the use of stimulants in narcolepsy, sleep disorders, and rehabilitation contexts.
South Australia, Tasmania, ACT and Northern Territory
The National Class Authority: What Changed in November 2023
A critical regulatory change that underpins much of the current framework occurred on 13 November 2023, when the Australian and New Zealand ADHD Professional Association (AADPA) coordinated the introduction of a national class authority for psychostimulant prescribing:
What the class authority means:
- Psychiatrists, paediatricians, and neurologists across all of Australia are now authorised under a class authority to prescribe psychostimulant medications (including Vyvanse up to 70 mg daily) for ADHD without needing to apply for individual patient permits in most circumstances
- This replaced the previous general authority (CNS or S28c) system that required more administrative steps
- The class authority does not apply to drug-dependent patients, off-label indications, or doses above the approved maximum
Where individual patient approval is still required:Even under the class authority, psychiatrists, paediatricians, and neurologists must apply for individual patient approval for:
- Drug-dependent patients
- Indications other than ADHD (e.g., prescribing Vyvanse for an unlisted indication)
- ADHD when doses exceed lisdexamfetamine 70 mg daily
- In NSW specifically, when prescribing under circumstances not covered by the class authority
How to Find a Prescriber: Practical Steps by Patient Type
New Patient (No Prior ADHD Diagnosis)
Best starting point by state:
- Queensland: Contact a fellowed GP (FRACGP/FACRRM) practice — they can now diagnose and initiate for adults without specialist referral
- NSW: GP referral to a psychiatrist remains the primary pathway; from March 2026, endorsed GP prescribers can also initiate
- All other states: GP referral to a psychiatrist or paediatrician; telehealth psychiatric services significantly reduce wait times
Telehealth options:Australian telehealth psychiatric services (including Akkadian Health, and other telehealth platforms with ADHD-specialist psychiatrists) can significantly reduce the wait for assessment in all states. Telehealth psychiatrists hold the same class authority as in-person psychiatrists.
Existing Patient (Already Diagnosed, Seeking Repeat Scripts)
Best approach:
- NSW: Find a registered GP continuation prescriber using the Healthdirect service finder or by calling 1800 022 222; as of January 2026, 749 are registered with 41% outside metropolitan Sydney
- Victoria: Confirm your GP holds a current Schedule 8 treatment permit; if not, they must apply before prescribing
- Queensland: Any GP in a shared care arrangement, or a fellowed GP with initiation authority
- WA and other states: Confirm a shared care arrangement is in place with your specialist; ask your GP whether they hold appropriate prescribing authority
Patient Returning from Overseas with Prior Overseas Diagnosis
- An overseas ADHD diagnosis is not automatically recognised for Australian PBS prescribing
- Present all documentation (assessment reports, prescription history, overseas medical records) to an Australian psychiatrist for review and formal Australian diagnosis
- A streamlined re-assessment is often possible when comprehensive overseas documentation is available, but cannot be skipped entirely
The PBS Prescribing Authority Requirements for Vyvanse
Accessing Vyvanse at the PBS subsidised price requires specific prescribing authority beyond just a clinical prescription:
The PBS authority conditions for Vyvanse:
- The patient must have a formal ADHD diagnosis with documented retrospective childhood onset
- The prescribing clinician must hold the appropriate PBS authority — for specialist initiators, this is through their class authority; for GP continuation prescribers, through their registered continuation status
- The prescription must include the valid approval number required by the relevant state health authority
Maximum PBS-subsidised dose:The PBS subsidises Vyvanse up to a maximum of 70 mg daily — the same as the TGA-approved maximum dose.
Private prescription vs. PBS prescription:Any authorised prescriber can write a private (non-PBS) prescription for Vyvanse without the specific PBS authority requirements, but the patient pays the full private cost. PBS prescriptions significantly reduce cost: approximately $31.60 per month standard rate versus $100–$150+ privately.
Common Misconceptions About Who Can Prescribe Vyvanse
Myth 1: “Any GP can prescribe Vyvanse.”Categorically incorrect. GPs without continuation prescriber status, without a co-management arrangement, or without fellowship and specialist GP training (in Queensland) cannot legally prescribe Vyvanse in Australia. The statement “any registered GP can prescribe Schedule 8” misrepresents the specific psychostimulant prescribing regulations that apply as an additional layer above general S8 authority.
Myth 2: “A psychologist can prescribe Vyvanse if they diagnose ADHD.”Psychologists have no prescribing authority in Australia for any medication. A thorough psychological assessment and formal ADHD diagnosis from a psychologist is clinically valuable — but it cannot result in a Vyvanse prescription from the psychologist themselves. The assessment must be reviewed by a prescribing clinician.
Myth 3: “The September 2025 reforms mean all GPs can now prescribe Vyvanse.”The September 2025 NSW reforms created a specific category of registered continuation prescribers — GPs who applied for and received this status after completing accredited training. As of January 2026, this is 749 GPs in NSW. The vast majority of GPs in NSW — and all GPs in most other states — still cannot prescribe Vyvanse independently.
Myth 4: “My GP’s prescription is fine because they have a PBS authority number.”PBS authority indicates Medicare will subsidise the cost — it does not indicate that the prescribing clinician has the necessary Schedule 8 prescribing authority under state law. In Victoria specifically, this is explicitly stated in the Department of Health guidance: a PBS authority prescription from a GP who does not hold an S8 treatment permit is unlawful regardless of the PBS number.
Who can prescribe Vyvanse Hobart
Who can prescribe Vyvanse Devonport
Who can prescribe Vyvanse Launceston
Who can prescribe Vyvanse Tasmania
Who can prescribe Vyvanse Victoria
Who can prescribe Vyvanse Queensland
Who can prescribe Vyvanse Canberra
Who can prescribe Vyvanse Australian Capital Territory
Who can prescribe Vyvanse South Australia
Who can prescribe Vyvanse New South Wales
Who can prescribe Vyvanse Darwin
Who can prescribe Vyvanse Ghan
Who can prescribe Vyvanse Northern Territory
Who can prescribe Vyvanse Australia
Who can prescribe Vyvanse Austria
Who can prescribe Vyvanse Germany
Who can prescribe Vyvanse United Kingdom
Who can prescribe Vyvanse Sweden
Who can prescribe Vyvanse Denmark
Who can prescribe Vyvanse Norway
Who can prescribe Vyvanse Finland
Who can prescribe Vyvanse Iceland
Who can prescribe Vyvanse Netherlands
Who can prescribe Vyvanse Spain
Who can prescribe Vyvanse Ireland
Who can prescribe Vyvanse Switzerland
FAQ: People Also Ask About Who Can Prescribe Vyvanse
Who can prescribe Vyvanse in Australia?Psychiatrists, paediatricians, and neurologists hold class authority to prescribe Vyvanse in all states. Specially trained GP continuation prescribers (from September 2025 in NSW, February 2026 in ACT) can prescribe for existing stable patients. Specialist GP fellows (FRACGP/FACRRM) in Queensland can diagnose and initiate for adults from December 2025. Endorsed GP prescribers in NSW can diagnose and initiate from March 2026. Nurse practitioners cannot prescribe Vyvanse in most states.
Can a GP prescribe Vyvanse in Australia?It depends on the state and the GP’s qualifications. In Queensland, FRACGP/FACRRM-fellowshipped GPs can diagnose and prescribe for adults (from December 2025) and children (since 2017). In NSW, registered GP continuation prescribers can continue prescriptions for existing patients, and endorsed prescribers can diagnose and initiate from March 2026. In Victoria, SA, WA, TAS, NT, GPs can prescribe under co-management arrangements but cannot initiate independently. No state allows all GPs to independently diagnose and prescribe.
Can a GP prescribe Vyvanse for the first time in Australia?Only in Queensland (for FRACGP/FACRRM fellows, adults from December 2025 and children since 2017) and NSW (for endorsed prescribers with additional accredited training, from March 2026). In all other states, the first Vyvanse prescription for a new ADHD diagnosis must be initiated by a psychiatrist, paediatrician, or neurologist.
Can a psychiatrist prescribe Vyvanse without a referral?Yes — psychiatrists hold class authority to prescribe Vyvanse without requiring a referral to prescribe. However, a GP referral is typically needed for patients to access a Medicare rebate for the initial psychiatric consultation (under the Medicare Benefits Schedule). The prescribing authority itself does not require a referral — the Medicare rebate for the consultation does.
Can a nurse practitioner prescribe Vyvanse in Australia?No — nurse practitioners are not authorised under Poisons and Therapeutic Goods legislation in NSW (and equivalently in most other states) to prescribe or supply Schedule 8 psychostimulant medicines including lisdexamfetamine. In WA, nurse practitioners may prescribe continuing stimulant medication under a shared care model, but cannot initiate.
Does the prescriber need to be in the same state as the patient for Vyvanse?No — psychiatrists, paediatricians, and neurologists practising outside a state can use the class authority to prescribe to patients who have their medication dispensed by a pharmacy in that state. NSW Health explicitly states: “Psychiatrists, paediatricians, or neurologists practising outside NSW can use the class authority to prescribe to patients who have their psychostimulant medicine dispensed by a NSW pharmacy”. This is particularly relevant for telehealth prescribers.
